Pangaea Oncology, S.A. reported earnings results for the half year ended June 30, 2021. For the half year, the company reported sales was EUR 0.951873 million compared to EUR 1.04 million a year ago. Net income was EUR 0.094668 million compared to net loss of EUR 0.566254 million a year ago.